Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
11/25/2009 | CN101589024A Novel minor groove binders |
11/25/2009 | CN101585857A Organic phosphine stabilized N-hydroxysuccinimide silver complex, synthesis method and application thereof |
11/25/2009 | CN101585796A Preparation method of piglet intestinal canal nutrition controlling substance-alpha-pyrrole formic acid |
11/25/2009 | CN101585795A Reaction method of catalyzing asymmetric alkyl by an (S) type thioic imidazolone compound |
11/25/2009 | CN101584694A Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method |
11/25/2009 | CN100562516C Beta-amyloid protein production/secretion inhibitors |
11/25/2009 | CN100562515C 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives |
11/25/2009 | CN100562511C 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
11/24/2009 | US7622597 Making maleimides such as 4,4'-bis(maleimide)diphenylmethane (BMI) by reacting a primary amine such as 4,4'-diaminodiphenylmethane with a maleic anhydride in an organic solvent in the presence of a betaine or sultaine catalyst |
11/24/2009 | US7622491 Modulators of PPAR and methods of their preparation |
11/24/2009 | US7622485 administering plant alkaloids such as 1-deoxy-galactonojirimycin and related compounds for prophylaxis of Fabry's disease |
11/24/2009 | CA2526145C C-glycoside derivatives or salts thereof for use as na+-glucose cotransporter inhibitors |
11/24/2009 | CA2415383C New amidino derivatives and their use as thrombin inhibitors |
11/24/2009 | CA2385882C Tyrosine derivatives |
11/24/2009 | CA2198745C Thermosetting resin compositions containing maleimide and/or vinyl compounds |
11/19/2009 | WO2009139792A1 Hcv protease inhibitors |
11/19/2009 | WO2009139730A1 Preparation of novel non-crystalline forms of atorvastatin calcium |
11/19/2009 | WO2009139373A1 Amide compound |
11/19/2009 | WO2009138763A1 Formation of 18f and 19f fluoroarenes bearing reactive functionalities |
11/19/2009 | WO2009138338A1 Novel n-(2-amino-phenyl)-acrylamides |
11/19/2009 | WO2009090544A3 Process for producing amorphous atorvastatin calcium |
11/19/2009 | US20090286994 Process for Synthesizing Nitramine Compounds |
11/19/2009 | US20090286993 Process for producing cyclic n-hydroxy imide compounds |
11/19/2009 | US20090286992 Formation of 18f and 19f fluoroarenes bearing reactive functionalities |
11/19/2009 | US20090286980 Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound |
11/19/2009 | US20090286976 One-pot synthesis of fluorinated ionic liquids |
11/19/2009 | US20090286848 Novel n-(2-amino-phenyl)-acrylamides |
11/19/2009 | US20090286841 Certain chemical entities, compositions, and methods |
11/19/2009 | US20090286833 Substituted Cyclohexylmethyl Compounds |
11/19/2009 | US20090286792 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
11/19/2009 | US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders |
11/19/2009 | US20090286001 Active-energy radiation-polymerizable substance, active-energy radiation-curable liquid composition, active-energy radiation-curable ink, ink jet recording method, ink cartridge, recording unit, and ink jet recording apparatus |
11/19/2009 | US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators |
11/19/2009 | CA2724077A1 Amide compound |
11/19/2009 | CA2724003A1 Novel n-(2-amino-phenyl)-acrylamides |
11/18/2009 | EP2119702A1 Amide derivative |
11/18/2009 | EP2119476A2 Amide derivatives as positive allosteric modulators and methods of use thereof |
11/18/2009 | EP2118056A2 Process for preparing vildagliptin |
11/18/2009 | EP2018367B1 Novel microbiocides |
11/18/2009 | EP1597229B1 Pyrrolidine derivatives as oxytocin antagonists |
11/18/2009 | EP1370525B1 Biguanide derivatives |
11/18/2009 | EP1358172B1 Amino ceramide-like compounds and therapeutic methods of use |
11/18/2009 | CN101580486A Method for synthesizing N-methylpyrrolidone catalyzed by particle type solid superacid |
11/18/2009 | CN101580465A Substituted phenyl keto enols as pesticides and herbicides |
11/18/2009 | CN100560623C Method for synthesizing halogen substituent maleimide heat-proof flame-proof resin emulsion |
11/18/2009 | CN100560566C Benzyloxy derivatives as MAOB inhibitors |
11/18/2009 | CN100560548C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
11/17/2009 | US7619097 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
11/17/2009 | US7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake |
11/17/2009 | US7618995 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
11/17/2009 | US7618981 Imidazopyridinyl-benzamide anti-cancer agents |
11/17/2009 | US7618978 Amides as BACE inhibitors |
11/17/2009 | CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity |
11/17/2009 | CA2422925C .delta.1-pyrrolines used as pesticides |
11/12/2009 | WO2009137810A2 Gold catalyzed hydroamination of alkynes and allenes |
11/12/2009 | WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
11/12/2009 | WO2009136290A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
11/12/2009 | WO2009114742A3 Stable bisthiol compounds for radioimaging and therapy |
11/12/2009 | WO2009098458A3 Difluorobiphenylamide derivatives for the treatment of ocular hypertension |
11/12/2009 | WO2003096987A9 Methods of use and compositions for the diagnosis and treatment of infectious disease |
11/12/2009 | US20090281332 Process for producing ester or alcohol |
11/12/2009 | US20090281331 Method of producing polycyclic proline derivative or acid addition salt thereof |
11/12/2009 | US20090281162 Crystalline forms of atorvastatin |
11/12/2009 | US20090281161 Organic Compounds |
11/12/2009 | US20090281094 Derivatives of 1--4-methylpiperazine, synthesis process and uses thereof |
11/12/2009 | US20090281085 3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity |
11/12/2009 | US20090281067 Nitroxyl progenitor compounds and methods of use |
11/12/2009 | CA2721815A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
11/11/2009 | EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
11/11/2009 | EP2116530A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents |
11/11/2009 | EP2114969A2 High stability polyionic liquid salts |
11/11/2009 | EP1848691B1 Process for the preparation of indolone derivative |
11/11/2009 | EP1742908B1 Non-nucleoside reverse transcriptase inhibitors |
11/11/2009 | EP1713823B1 Hcv ns-3 serine protease inhibitors |
11/11/2009 | EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity |
11/11/2009 | EP1597262B1 Substituted heterocycles |
11/11/2009 | CN101578262A Radiolabelling via fluorination of aziridines |
11/11/2009 | CN101575312A Substituted phenyl keto enols as pesticides and herbicides |
11/11/2009 | CN101575309A Method for synthesizing (S)-oxiracetam |
11/11/2009 | CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
11/11/2009 | CN100558409C Thiotungstate analogues and uses thereof |
11/10/2009 | US7615648 Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake |
11/10/2009 | US7615647 Process for producing atorvastatin hemicalcium |
11/10/2009 | US7615645 catalyzing the hydroformylation in the presence of a homogeneous rhodium catalyst that is complexed with an organophosphorus ligand; producing valeraldehyde from1-butene |
11/10/2009 | US7615635 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics |
11/10/2009 | US7615572 Pyrrole and pyrazole DAAO inhibitors |
11/10/2009 | US7615568 3-[2-(cis-4-aminocyclohexyloxy)-4-methylsulfonylbenzoyl-amino]-N-(5-chloropyridin-2-yl)pyridine-2-carboxamide,; anticoagulant; platelet glycoprotein receptor antagonist; thrombosis; orally; acylation of amino-pyridine by (methylthio)benzoic acid followed by oxidation, alkylation, carbonylation |
11/10/2009 | US7615566 Substituted pyrrolidine and related compounds |
11/10/2009 | US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation |
11/10/2009 | CA2454500C Crystalline forms vi and vii of atorvastatin calcium |
11/10/2009 | CA2368352C Method for treating neurodegeneration |
11/10/2009 | CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
11/05/2009 | WO2009133861A1 Cyclic amine compound |
11/05/2009 | WO2009132453A1 Cyclylamine derivatives as calcium channel blockers |
11/05/2009 | WO2008095064A3 High stability diionic liquid salts |
11/05/2009 | US20090275752 Novel Process for Statins and its Pharmaceutically Acceptable Salts Thereof |
11/05/2009 | US20090275714 New Ruthenium Complexes as Catalysts for Metathesis Reactions |
11/05/2009 | US20090275703 Process for cross-linking copolymers using a sulfur-containing co-agent |
11/05/2009 | US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases |
11/05/2009 | US20090275617 such as 3-[(1S,3R)-3-fluorocyclopentylamino]methyl-5-(5-fluoro-6-methylpyridin-3-yl)-1-isopropyl-4-methyl-1H-pyrazole, having opioid receptor antagonistic activity, used analgesics or for the treatment of diabetes, neurodegenerative diseases, drug abuse, hypotension, schizophrenia , dementia or obesity |